Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2021 Mar 22;123(7):1642–1644. doi: 10.1002/jso.26414

Comment on “Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS‐CoV‐2: A case‐control study from a single institution”

Qiang Hu 1, Yuanshui Sun 1, Jian Chen 1,✉
PMCID: PMC8250813  PMID: 33751573

To the Editor,

We have read with interest the article published by Baiocchi Glauco et al. 1 At present, severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) has spread rapidly in the world, and it has become the biggest threat and challenge in the world. In the current environment, this study has a good guiding role for clinical work. Although we believe it is a very interesting topic, we would like to offer the following points for your consideration.

First, in Table 2, 1 we need to compare the surgical methods of the two groups (COVID‐neg group VS COVID‐rec group), such as open surgery and minimally invasive surgery. Many studies have shown that the postoperative complications of minimally invasive surgery are significantly lower than that of open surgery. 2 , 3 , 4 So we need to exclude the influence of surgical methods on the complications of the two groups.

Table 1.

Clinical and demographic characteristics of the 147 patients submitted to surgical procedures from April 22 to July 2, 2020

Variable 1 COVID‐nega group n = 98 (%) COVID‐recb group n = 49 (%) p value Total 147 (%)
Age, mean; median (range), year 49.8; 51 (16–81) 50.1; 52 (13–81) .86 49.9; 51 (13–81)
Body mass index, mean; median (range), kg/m2 26.8; 25.9 (16.9–53.9) 27.6; 27.5 (18.8–43) .33 27.1; 26.6 (16.9–53.9)
Surgical time length, mean; median (range), min 119.0; 100 (10–670) 110.2; 79 (10–362) .54 116.1; 93 (10–670)
Hospital stay length, mean; median (range), days 3.48; 1.0 (0–62) 3.08; 1.0 (0–47) .28 3.35; 1.0 (0–62)
Gender Male 40 (40.8) 16 (33.3) .38 56 (38.4)
Female 58 (59.2) 32 (66.7) 90 (61.6)
ASAc 1 and 2 82 (83.7) 44 (89.8) .31 126 (85.7)
3 and 4 16 (16.3) 5 (10.2) 21 (14.3)
ECOGd 0 and 1 83 (84.7) 42 (85.7) .87 125 (85.0)
2 and 3 15 (15.3) 7 (14.3) 22 (15.0)
Surgical type Oncological 53 (54.1) 25 (51.0) .72 78 (53.1)
Nononcological 45 (45.9) 24 (49.0) 69 (46.9)
Surgical Department Gastrointestinal 17 (17.3) 10 (20.4) .73 27 (18.4)
Gynecology 16 (16.3) 10 (20.4) 26 (17.7)
Breast 21 (23.5) 5 (14.3) 26 (17.7)
Skin Cancer 14 (14.3) 5 (10.2) 19 (12.9)
Urology 12 (12.2) 7 (14.3) 19 (12.9)
Head and Neck 11 (11.2) 7 (14.3) 7 (14.3)
Otherse 8 (8.2) 4 (8.2) 12 (8.2)
Intensive care unit No 92 (93.9) 41 (85.4) .12 133 (91.1)
Yes 6 (6.1) 7 (14.6) 13 (8.9)
Morbidity (Clavien–Dindo)f none 84 (85.7) 41 (83.7) .74 125 (85.0)
I 1 (1.0) 2 (4.1) 3 (2.0)
II 7 (7.1) 2 (4.1) 9 (6.1)
IIIa 3 (3.1) 3 (6.1) 6 (4.1)
IIIb 1 (1.0) 1 (2.0) 2 (1.4)
IVa 1 (1.0) 0 (0) 1 (0.7)
IVb 1 (1.0) 0 (0) 1 (0.7)
a

COVID‐neg: patients that had surgeries after a negative RT‐PCR test for SARS‐CoV‐2.

b

COVID‐rec: asymptomatic patients that had surgeries delayed due to positive RT‐PCR test for SARS‐CoV‐2.

c

ASA: American Society of Anesthesiologists risk classification.

d

ECOG: Eastern Cooperative Oncology Group Performance Status.

e

Others: Vascular surgery, Intervention Radiology, Neurosurgery and Reconstructive Surgery.

f

Clavien–Dindo: Clavien–Dindo classification of surgical complications.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Second, in Table 2, 1 the surgical type are divided into Oncological and Nononcological, but there is no comparison of tumor stages in the two groups of tumor patients. As we all know, patients with different tumor stages have different surgical resection range, different trauma, and different probability of complications. Some studies have shown that the incidence of postoperative complications in patients with late tumor staging is higher than that in patients with early tumor staging because of the wide range of surgical resection. 5 , 6

Third, at present, enhanced recovery after surgery (ERAS) has become a global research hotspot, because it can reduce stress response, shorten postoperative hospital stay, reduce postoperative hospital costs and complications, so it is widely used all over the world. 7 , 8 Therefore, the effect of ERAS on the complications of the two groups should be excluded.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

Qiang Hu drafted the letter and Jian Chen and Yuanshui Sun critically reviewed the article.

ACKNOWLEDGMENTS

This study was funded by the Science and Technology Planning Project of Zhejiang Province (No. 2017F30045), Science and Technology Planning Project of Traditional Chinese Medicine(No.2018ZZ004), Gastrointestinal surgery of integrated traditional Chinese and Western Medicine (No. 2017‐XK‐A20).

REFERENCES

  • 1. Glauco B, Samuel A, Duprat JP, et al. Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS‐CoV‐2: a case‐control study from a single institution. J Surg Oncol. 2021. 10.1002/jso.26377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Gottlieb‐Vedi E, Kauppila JH, Mattsson F, et al. Long‐term survival in esophageal cancer after minimally invasive esophagectomy compared to open esophagectomy. Ann Surg. 2021. Publish Ahead of Print 10.1097/SLA.0000000000004645 [DOI] [PubMed] [Google Scholar]
  • 3. Obermair A, Asher R, Pareja R, et al. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2020;222(249):e1‐249.e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. van der Wielen N, Jennifer S, Cuesta Miguel A, Freek D, van der Peet DL. Short‐term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature. Gastric Cancer. 2018;21:19‐30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Yoon JY, Sigel K, Martin J, et al. Evaluation of the prognostic significance of TNM staging guidelines in lung carcinoid tumors. J Thorac Oncol. 2019;14:184‐192. [DOI] [PubMed] [Google Scholar]
  • 6. Sergio Pedrazzoli. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging. Cancer Treat Rev. 2015;41:577‐587. [DOI] [PubMed] [Google Scholar]
  • 7. Liska David NM, Cengiz BT, Holubar SD, et al. Enhanced recovery pathway benefits patients undergoing nonelective colorectal surgery. Ann Surg. 2019. 10.1097/SLA.0000000000003438 [DOI] [PubMed] [Google Scholar]
  • 8. Williams SB, Cumberbatch MGK, Kamat AM, et al. Reporting radical cystectomy outcomes following implementation of enhanced recovery after surgery protocols: a systematic review and individual patient data meta‐analysis. Eur Urol. 2020;78:719‐730. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Surgical Oncology are provided here courtesy of Wiley

RESOURCES